Barclays PLC Tiziana Life Sciences LTD Transaction History
Barclays PLC
- $288 Billion
- Q1 2024
A detailed history of Barclays PLC transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Barclays PLC holds 17,500 shares of TLSA stock, worth $16,100. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,500
Previous 17,500
-0.0%
Holding current value
$16,100
Previous $10,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding TLSA
# of Institutions
21Shares Held
816KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA216KShares$198,5590.0% of portfolio
-
Hsbc Holdings PLC London, X0164KShares$151,0870.0% of portfolio
-
Morgan Stanley New York, NY126KShares$116,0460.0% of portfolio
-
Ausdal Financial Partners, Inc. Davenport, IA55.7KShares$51,2440.0% of portfolio
-
Ewa, LLC Pittsbugh, PA55.3KShares$50,8760.02% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $94.1M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...